Wuhan Keqian Biology Co Ltd
SSE:688526
Wuhan Keqian Biology Co Ltd
SSE:688526
Price:
15.59
CNY
0.71%
Market Closed
Market Cap:
¥7.3B
Cash Flow Statement
Cash Flow Statement
Wuhan Keqian Biology Co Ltd
Wuhan Keqian Biology Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(100)
|
(130)
|
(122)
|
(108)
|
(87)
|
(109)
|
(92)
|
(93)
|
(97)
|
(91)
|
(89)
|
(95)
|
33
|
(7)
|
(6)
|
(110)
|
(124)
|
(91)
|
(93)
|
|
| Change in Working Capital |
(193)
|
(294)
|
(215)
|
(201)
|
(242)
|
(227)
|
(269)
|
(315)
|
(272)
|
(295)
|
(316)
|
(312)
|
31
|
79
|
87
|
(236)
|
(258)
|
(275)
|
(267)
|
|
| Cash from Operating Activities |
400
N/A
|
649
+62%
|
562
-13%
|
515
-8%
|
531
+3%
|
389
-27%
|
438
+13%
|
389
-11%
|
424
+9%
|
495
+17%
|
460
-7%
|
538
+17%
|
(45)
N/A
|
(60)
-33%
|
(173)
-188%
|
393
N/A
|
400
+2%
|
405
+1%
|
435
+7%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(112)
|
(228)
|
(301)
|
(330)
|
(374)
|
(280)
|
(201)
|
(149)
|
(103)
|
(102)
|
(86)
|
(92)
|
10
|
11
|
28
|
(107)
|
(114)
|
(120)
|
(121)
|
|
| Other Items |
(1 079)
|
(968)
|
(979)
|
(429)
|
43
|
(138)
|
32
|
(210)
|
(534)
|
(464)
|
(767)
|
(389)
|
236
|
459
|
186
|
204
|
(97)
|
25
|
(210)
|
|
| Cash from Investing Activities |
(1 190)
N/A
|
(1 196)
0%
|
(1 280)
-7%
|
(759)
+41%
|
(331)
+56%
|
(418)
-26%
|
(168)
+60%
|
(359)
-113%
|
(637)
-78%
|
(566)
+11%
|
(853)
-51%
|
(481)
+44%
|
246
N/A
|
470
+91%
|
214
-54%
|
97
-55%
|
(211)
N/A
|
(95)
+55%
|
(330)
-247%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Debt |
60
|
30
|
10
|
48
|
18
|
20
|
(10)
|
(38)
|
194
|
337
|
287
|
237
|
(217)
|
(100)
|
(264)
|
(286)
|
0
|
(232)
|
0
|
|
| Cash Paid for Dividends |
(0)
|
(1)
|
(128)
|
(166)
|
(137)
|
(137)
|
(96)
|
(57)
|
(93)
|
(95)
|
(95)
|
(97)
|
0
|
(115)
|
(115)
|
(205)
|
0
|
(201)
|
(200)
|
|
| Other |
1 146
|
0
|
0
|
(7)
|
(2)
|
(2)
|
1
|
5
|
13
|
0
|
10
|
3
|
(24)
|
(25)
|
(31)
|
(12)
|
11
|
29
|
35
|
|
| Cash from Financing Activities |
1 206
N/A
|
1 175
-3%
|
1 028
-12%
|
(126)
N/A
|
(121)
+4%
|
(119)
+2%
|
(105)
+12%
|
(90)
+15%
|
114
N/A
|
255
+125%
|
202
-21%
|
143
-29%
|
(240)
N/A
|
(240)
+0%
|
(410)
-71%
|
(503)
-23%
|
(377)
+25%
|
(404)
-7%
|
(222)
+45%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
416
N/A
|
629
+51%
|
310
-51%
|
(370)
N/A
|
79
N/A
|
(148)
N/A
|
165
N/A
|
(60)
N/A
|
(100)
-67%
|
185
N/A
|
(191)
N/A
|
201
N/A
|
(39)
N/A
|
170
N/A
|
(369)
N/A
|
(14)
+96%
|
(189)
-1 257%
|
(94)
+50%
|
(117)
-24%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
289
N/A
|
421
+46%
|
261
-38%
|
185
-29%
|
157
-15%
|
109
-31%
|
238
+119%
|
240
+1%
|
321
+34%
|
394
+23%
|
374
-5%
|
447
+19%
|
(35)
N/A
|
(49)
-39%
|
(144)
-195%
|
286
N/A
|
285
0%
|
285
+0%
|
314
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
